Evidence map›Paper›PMID 31235580›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke.

Ruslan Rust, Lisa Grönnert, Christina Gantner, Alinda Enzler, Geertje Mulders, Rebecca Z Weber, Arthur Siewert, Yanuar D P Limasale, Andrea Meinhardt, Michael A Maurer and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 150 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Monocyte-derived macrophages and their roles in ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  8. Article
  9. "Time Is Brain" - for Cell Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The blood-brain barrier: a help and a hindrance.Brain : a journal of neurology · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Ruslan RustInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland; rust@irem.uzh.ch schwab@irem.uzh.ch.ORCID 0000-0003-3376-3453
Lisa GrönnertInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland.
Christina GantnerDepartment of Biology, ETH Zurich, 8093 Zurich, Switzerland.
Alinda EnzlerDepartment of Health Sciences and Technology, ETH Zurich, 8092 Zurich, Switzerland.
Geertje MuldersInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland.
Rebecca Z WeberInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland.
Arthur SiewertDepartment of Technology, Bielefeld University, 33615 Bielefeld, Germany.
Yanuar D P LimasaleLeibniz Institute for Polymer Research, 01069 Dresden, Germany.
Andrea MeinhardtLeibniz Institute for Polymer Research, 01069 Dresden, Germany.
Michael A MaurerInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland.
Andrea M SartoriInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland.
Anna-Sophie HoferInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland.
Carsten WernerLeibniz Institute for Polymer Research, 01069 Dresden, Germany.
Martin E SchwabInstitute for Regenerative Medicine, University of Zurich, 8952 Schlieren, Switzerland; rust@irem.uzh.ch schwab@irem.uzh.ch.
University of Zurich · CHLeibniz Institute of Polymer Research · DEETH Zurich · CHBielefeld University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a major cause of serious disability due to the brain's limited capacity to regenerate damaged tissue and neuronal circuits. After ischemic injury, a multiphasic degenerative and inflammatory response is coupled with severely restricted vascular and neuronal repair, resulting in permanent functional deficits. Although clinical evidence indicates that revascularization of the ischemic brain regions is crucial for functional recovery, no therapeutics that promote angiogenesis after cerebral stroke are currently available. Besides vascular growth factors, guidance molecules have been identified to regulate aspects of angiogenesis in the central nervous system (CNS) and may provide targets for therapeutic angiogenesis. In this study, we demonstrate that genetic deletion of the neurite outgrowth inhibitor Nogo-A or one of its corresponding receptors, S1PR2, improves vascular sprouting and repair and reduces neurological deficits after cerebral ischemia in mice. These findings were reproduced in a therapeutic approach using intrathecal anti-Nogo-A antibodies; such a therapy is currently in clinical testing for spinal cord injury. These results provide a basis for a therapeutic blockage of inhibitory guidance molecules to improve vascular and neural repair after ischemic CNS injuries.

Indexed as

AnimalsAntibodies, Anti-IdiotypicBrainBrain IschemiaCentral Nervous SystemDisease Models, AnimalHumansMiceNeovascularization, PhysiologicNeuronsNogo ProteinsPyramidal TractsRecovery of FunctionSphingosine-1-Phosphate ReceptorsSpinal Cord InjuriesStrokeAntibodies, Anti-IdiotypicNogo Proteinssphingosine-1-phosphate receptor-2, mouseSphingosine-1-Phosphate ReceptorsCNSguidance factorischemiarevascularizationtherapeutic angiogenesis

Identifiers

PMID31235580
PMCPMC6628809
OpenAlexW2954637808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.